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Background: Host defence peptides are important components of mammalian innate immunity. We have
previously shown that PR-39, a cathelicidin host defence peptide, is an important factor in porcine innate immune
mechanisms as a first line of defence after infection with Actinobacillus pleuropneumoniae. PR-39 interacts with
bacterial and mammalian cells and is involved in a variety of processes such as killing of bacteria and promotion of
wound repair. In bronchoalveolar lavage fluid of infected pigs PR-39 concentrations are elevated during the chronic
but not during the acute stage of infection when polymorphonuclear neutrophils (known as the major source of
PR-39) are highly increased. Thus it was assumed, that the real impact of PR-39 during infection might not be
reflected by its concentration in bronchoalveolar lavage fluid.
Results: Using immunohistochemistry this study demonstrates the actual distribution of PR-39 in tissue of the
upper and lower respiratory tract of healthy pigs, and of pigs during the acute and chronic stage of experimental
infection with Actinobacillus pleuropneumoniae.
During the acute stage of infection PR-39 accumulated adjacent to blood vessels and within bronchi. Immune
reactions were mainly localized in the cytoplasm of cells with morphological characteristics of polymorphonuclear
neutrophils as well as in extracellular fluids. During the chronic stage of infection pigs lacked clinical signs and lung
alterations were characterized by reparation and remodelling processes such as tissue sequestration and fibroblastic
pleuritis with a high-grade accumulation of small PR-39-positive cells resembling polymorphonuclear neutrophils. In
healthy pigs, PR-39 was homogenously expressed in large single cells within the alveoli resembling alveolar
macrophages or type 2 pneumocytes. PR-39 was found in all tissue samples of the upper respiratory tract in healthy
and diseased pigs. Within the tracheobronchial lymph nodes, PR-39 dominated in the cytoplasm and nuclei of large
cells resembling antigen-presenting cells located in the periphery of secondary follicles.
Conclusions: These immunohistochemical findings indicate that, in addition to polymorphonuclear neutrophils,
other cells are involved in the expression, storage, or uptake of PR-39. The presence of PR-39 in healthy lung tissue
showed that this antibacterial peptide might be important for the maintenance of health.
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Multifactorial respiratory diseases are an important cause
of economic losses in the swine industry [1,2]. Microbial
colonization and invasion, and abiotic factors, such as
climate, social stress and nutrition, as well as host factors
like innate and adaptive immune responses, are decisive for
the outcome of disease [3,4]. Knowledge of the distribution
of key factors of the innate immune system is important
not only for examining host-pathogen-interactions but also
for assessing vaccination strategies with respect to a
successful stimulation of the innate immune system of the
respiratory tract. Pigs have several host defence peptides
with ß-defensins and cathelicidins as the most important
ones. With eleven porcine cathelicidins the pig is endowed
with the most diverse family of cathelicidins compared to
other species [5]. Linear proline-rich cathelicidins such as
PR-39 form a type II poly-L-proline helix facilitating an
interaction with bacterial and mammalian cells without
translocation across biological membranes. The high pro-
line content of this peptide may explain its stability in
highly proteolytical microenvironments (e.g. inflammation
sites, mucosal surfaces) [5]. PR-39 was initially character-
ized as an antibacterial factor in the intestine of pigs [6,7].
Increased serum PR-39 levels have been found after infec-
tion with Salmonella choleraesuis [5,8]. PR-39 is also
known as a multifunctional peptide involved in a variety of
processes, including promotion of wound repair, induction
of angiogenesis, regulation of apoptosis, neutrophil chemo-
taxis and inhibition of NADPH oxidase activity [5,7]. PR-39
is released in wound fluid by recruited polymorphonuclear
neutrophils (PMNs) and serves as a signalling factor for the
induction of syndecan [9].
For investigating host-pathogen interactions during pneu-
monia, standardised infection models are indispensable.
Infection with Actinobacillus pleuropneumoniae (A.pp.), a
highly pathogenic bacterial porcine respiratory tract patho-
gen, is well established for examining porcine host reactions
as well as changes in bacterial virulence factor expression
during infection [10,11]. The chronic stage of A.pp.
infection is characterised by reparative processes like
sequestered necroses and persistent pleural adhesions
[12,13]. The concentration of PR-39 was significantly
increased in bronchoalveolar lavage fluid and correlated to
PMNs as well as to the lung lesion score in this chronic
stage of A.pp. infection. It was assumed that the neutro-
philic origin of PR-39 as well as a hypothetical involvement
in tissue repair processes were the reason for this observa-
tion [9,14]. No correlation of PR-39 concentrations with
cellular parameters was found in the acute stage of A.pp.
infection in bronchoalveolar lavage fluid although PMNs
were highly increased [14]. It was anticipated that the real
impact of PR-39 during different stages of infection might
not be reflected by its concentration in bronchoalveolar
lavage fluid.Our research hypothesis was that not only PMNs but also
other cells were involved in the expression, storage, or up-
take of PR-39. Furthermore, it was assumed that PR-39
positive cells can only be detected in tissue of diseased pigs.
Methods
Experimental infection and clinical investigations
German Landrace pigs of both sexes used in this study
were 6 to 7 weeks old and originated from a single herd
routinely monitored and free from endo- and ectopara-
sites, toxigenic Pasteurella multocida, A.pp. and Porcine
Reproductive and Respiratory Syndrome Virus. In previ-
ous studies, the German Landrace, as one of the most
common purebred pigs in Germany has been found to
be highly susceptible towards A.pp. infection and has
proven itself to be suitable for reliable and repeatable
challenge experiments [11]. Immunohistological examin-
ation of tissue samples was performed on three healthy
mock-infected pigs and eight pigs infected with A. pp.
serotype 7 in the acute (2) and chronic (6) stage of infec-
tion (Table 1). Groups were housed in separate isolation
units under standard conditions and cared for in accord-
ance with the principles outlined by the European Con-
vention for the Protection of Vertebrate Animals used for
Experimental and Other Scientific Purposes (European
Treaty Series, nos. 123 [http://conventions.coe.int/treaty/
EN/treaties/html/123.htm] and 170 [http://conventions.
coe.int/treaty/EN/treaties/html/170.htm]; approval num-
ber: 33-42502-05/ 941) and clinical signs were monitored
daily. Aerosol infection was performed using the A. pp.
serotype 7 strain AP76 diluted in 154 mM sodium chlor-
ide resulting in approximately 1 x 105 colony forming
units per millilitre suspension for nebulization as previously
described [15,16]. 154 mM sterile sodium chloride was used
for mock infection. The project was approved from the
Lower Saxony State Office for Consumer Protection and
Food Safety as the responsible regulatory authorities and in
accordance with the requirements of the national animal
welfare law fulfilling also international recognized guide-
lines (approval number: 33-42502-05/ 941).
In all pigs living until day 21 after infection, bacterio-
logical examination and PCR analysis of altered and un-
altered lung tissue were performed to determine
persistent infection with A.pp.. In addition, lung tissue
samples of two mock infected control pigs (Table 1, pigs
2 and 3) were examined for colonizing bacterial species.
Pigs were necropsied and lung lesions were analysed fol-
lowing the evaluation scheme proposed by Hannan et al.
[17]. In brief, the size and position of lesions were
mapped on a simplified lung chart representing the
seven lung lobes, which are subdivided into triangles. A
maximum possible score of 5 can be allotted to each
lung lobe. The number of affected triangles in one lung
lobe represents the pneumonic area, which is assessed as
Table 1 Macroscopic and microscopic findings in lungs of mock-infected pigs and pigs infected with Actinobacillus
pleuropneumoniae





1 mock 21 0 Predominantly without pathological findings, small areas with
slight interstitial pneumonia
2 mock 21 3.6 Predominantly without pathological findings, small areas with
slight interstitial pneumonia
3 mock 21 0 Predominantly without pathological findings, small areas with
slight interstitial pneumonia
4 A.pp. serotype 7
strain AP76
1 17.7 Severe purulent and fibrinous pneumonia, moderate
interstitial pneumonia
5 A.pp. serotype 7
strain AP76
21 12.3 Severe catarrhal and purulent bronchopneumoniae with
abscesses, slight interstitial pneumonia
6 A.pp. serotype 7
strain AP76
21 6.3 Severe purulent pneumonia with abscesses and sequesters with
colliquative necrosis
7 A.pp. serotype 7
strain AP76
21 0 Predominantly without pathological findings, small areas with
severe interstitial pneumonia
8 A.pp. serotype 7
strain AP76
21 4.4 Moderate catarrhal and purulent bronchopneumonia with
abscesses, moderate interstitial pneumonia
9 A.pp. serotype 7
strain AP76
21 0 Most areas without pathological findings, small areas with
severe interstitial pneumonia
10 A.pp. serotype 7
strain AP76
4 31.4 Severe purulent and necrotic bronchopneumonia,
fibrinous tissue alterations
11 A.pp. serotype 7
strain AP76
21 6.4 Severe purulent pneumonia with fibrotic tissue alterations,
moderate interstitial pneumonia
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the complete lung). Lung lesion scores and the findings
of histological tissue examination are shown in Table 1.Immunohistochemistry for PR-39
Tissue samples were collected following a standard proto-
col to ensure the comparability of equal localizations in
different individuals. The head was separated from the body
and cut paramedially in a longitudinal direction, and, subse-
quently, transversally at a level with the first premolar tooth
to expose the nasal cavity. The nasal septum was removed.
To follow the route of natural lung infection, tissue
sampling was performed as follows: a disc-shaped transver-
sal cut sample of the dorsal and ventral nasal concha was
taken; subsequently, samples from the pharyngeal tonsil
and trachea (approximately 50 mm cranial to the
bifurcation) were excised. Samples were taken from the
caudal lung lobes from unaltered and altered lung tissue
well as from the tracheobronchial lymph nodes. Samples
were fixed in Bouin’s fluid containing 0.9% picric acid, 9%
formaldehyde and 5% glacial acetic acid for 48 h at room
temperature and afterwards dehydrated in a graded series
of ethanol before embedding through xylene in paraffin
wax (Paraplast plus, Tyco Health Care). Paraffin sections
(8 μm) were cut with a motor driven rotation microtome
(Autocut, Reichert-Jung), deparaffinised in Histoclear
(Life Science Int.) and hydrated through descendingconcentrations of ethanol. Routinely, histological sections
were either stained with haematoxylin-eosin (HE,
haemalaun after Delafield) or with Masson’s trichrome
stain. For detecting PR-39, the sections were stained
immunohistochemically with a monoclonal mouse anti-
PR-39-antibody [8] in a dilution of 1:400 overnight after
a thirty-minute incubation step with normal goat serum
(BioGenex, San Ramon, USA). Subsequently, a second-
ary immunohistochemical detection system employing
an indirect biotin-streptavidin amplified system was
performed according to the manufacturer’s instructions
(Super SensitiveTM Link-Label IHC Detection System,
BioGenex, San Ramon, USA). In brief, tissue sections
were incubated with a biotinylated anti-mouse immun-
globulin and then with Horseradish Peroxidase-labelled
streptavidin. The entire antibody-enzyme complex was
made visible by the addition of a 3, 3’-diaminobenzidine
(DAB) chromogen solution. Control sections were
incubated without the first antibody. Sections were photo-
graphed with a Zeiss Photomicroscope II equipped with a
digital camera (Olympus DP70).Results and discussion
Development of porcine pleuropneumonia in infected
animals
All infected pigs developed acute clinical signs such as
an increase in body temperature, inappetence, lethargy
Figure 1 Immunohistochemical demonstration of PR-39 positive cells in lung tissue of mock infected pig 3. A) Semiserial haematoxylin-
eosin stained histological section, bar 50 μm. B) PR-39 positive cells are distributed evenly within the lung tissue. Single large positive cells in the
walls of every alveolus, bar 50 μm.
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and were assessed as clinically healthy before necropsy
on day 21/22. Two pigs (Table 1: pigs 4 and 10) died
during the acute stage of infection from severe pneumo-
nia. Mock infected animals showed no clinical signs
(Table 1). Fibrinous pleuritis and pneumonia as well as
lung oedema and haemorrhage dominated in the first
four days after infection, while fibroblastic pleuritis and
lung tissue sequestration were found in four chronically
infected pigs. Mock-infected pig 2 showed a slight catar-
rhalic purulent bronchopneumonia of the right cranial
lung lobe characteristic for enzootic pneumonia. A
histological examination revealed an interstitial pneumo-
nia in nearly all pigs (Table 1). Whether interstitial pneu-
monia is a balanced reaction to commensal bacteria or
due to other microorganisms belonging to the Porcine
Respiratory Disease Complex, e.g. Mycoplasma hyopneu-
moniae and Porcine Circovirus 2, cannot be answered.
In a recent study 50% of healthy Danish finishing pigs
used as control animals for histopathological examin-
ation showed microscopic lung alterations [1].
A.pp. could be reisolated from the six infected pigs
with lung alterations. Mock infected pigs stayed negative
for A.pp.; Isolated bacterial species (Bordetella bronchi-
septica, Escherichia coli, α-haemolytic streptococci)
belonged to the spectrum of species which are isolatedFigure 2 PR-39 positive cells in lung tissue of pig 11 on day 21 after
with necrotic areas characterized by pyknosis (arrows) and amorphous cellu
areas, bar 50 μm.regularly from bronchoalveolar lavage fluid samples of
clinically healthy and specific pathogen-free pigs. The
presence of a normal flora of the upper respiratory tract
is assumed [18].
Demonstration of PR-39 in lung tissue of infected and
non-infected pigs
Positive staining reactions for PR-39 were obtained from
all organ tissue samples (lung, upper airways, lymphatic)
of all animals examined. However, striking differences
between healthy and diseased pigs were only found in
the tissue samples from the lung. In unaltered lung tis-
sue of infected and uninfected pigs PR-39-positive cells
were evenly distributed in the pulmonary tissue and
were regarded as alveolar pneumocytes type 2 or alveo-
lar macrophages due to their location within the alveolar
wall (1–2 cells/alveolus, Figure 1). The presence of PR-
39 in healthy lung tissue might be one important factor
for the maintenance of health as a dynamically balanced
process under the influence of microorganisms, environ-
mental factors and host reactions.
During acute infection positive cells accumulated at
the pleura, around blood vessels and bronchi and in
bronchial secretions which are dominated by PMNs.
Surprisingly, no correlation between the concentration
of free PR-39 and cellular parameters in bronchoalveolarinfection. A) Semiserial haematoxylin-eosin stained histological section
lar debris, bar 50 μm. B) PR-39 positive cells occur within necrotic
Figure 3 PR-39 positive cells in the lumen of bronchi of pig 5 on day 21 after infection. A) Semiserial haematoxylin-eosin stained
histological section. The morphology of cells in the lumen of bronchus resemble PMNs, bar 50 μm. B) PR-39 localization in the cytoplasm and
nucleus of small cells in the lumen of a bronchus, bar 50 μm.
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stage of infection. In the chronic stage of infection
PR-39-positive small cells accumulated in demarcation
zones to necrotic areas and also occur within necrotic
areas (Figure 2) as well as in the bronchial spaces
(Figure 3). The immunopositive signal was located in
the nucleus and in the cytoplasm.
Concentration of PR-39 in epithelial lining fluid
(ELF) covering the airways is deduced to be approxi-
mately 200 nM in diseased pigs [14]. In vitro, no bac-
tericidal activity of PR-39 against A.pp. has been
previously observed , although bactericidal activity of
PR-39 is well documented against other gram-negative
bacteria with lower concentrations [19-21]. Resistance
of A.pp. to PR-39 is in accordance with the in vivo ob-
servation that A.pp. persists for extended periods of
time on the respiratory epithelium of pigs [22,23].
Most probably, PR-39 plays a synergistic role with
other antimicrobial factors in the porcine respiratory
tract, as has been shown for other antimicrobial pep-
tides at sub-inhibitory concentrations [24,25]. The
multiplicity of antimicrobial factors in the ELF and
their synergistic effects might reduce the time available
for bacteria to develop a more virulent phenotype. Fur-
thermore, the combination of antimicrobials mightFigure 4 Immunohistochemical demonstration of PR-39 in nasal muc
histological section, bar 50 μm. B) PR-39 is localized within the cytoplasm o
in subepithelial tissue, bar 50 μm.prevent emergence of strains resistant to endogenous
antimicrobials [25].
Demonstration of PR-39 in the upper respiratory tract
and lymphatic tissue
The PR-39 staining pattern of nasal and tracheal mucosa,
pharyngeal tonsil and tracheobronchial lymphnodes was
similar in infected and non-infected pigs. This may re-
flect the fact that the mucosa of the upper respiratory
tract, which is known to be colonized by a commensal
microbial flora, is continuously influenced by environ-
mental as well as internal factors and demands an in-
nate system of constitutively produced stabilizing and
homeostatic substances. Porcine beta-defensin as the
other prominent porcine host defence peptide was
identified previously in epithelial cells of the porcine
tongue and buccal mucosa in healthy pigs. The intrae-
pithelial defensin shows synergistic bactericidal activity
with PR-39 from inflammatory neutrophils and is sup-
posed to enhance microbicidal defence in porcine mu-
cosal surfaces [26].
An accumulation of PR-39 positive cells was observed
around epithelial lesions, which were more frequent in
infected animals. In general, according to morpho-
logical characteristics, different cell types appearedosa of mock infected pig 3. A) Semiserial haematoxylin-eosin stained
f small positive cells with segmented nuclei resembling PMNs (arrows)
Figure 5 Immunohistochemical demonstration of PR-39 positive cells in the tracheobronchial lymph node of pig 6 on day 21 after
infection. A) Semiserial haematoxylin-eosin stained histological section, bar 50 μm. B) Large PR-39 positive cells are localized within the cortical
and medullar parenchyma, to a lesser extent in intermediary and subcapsular sinus, but not within the secondary nodules, bar 50 μm.
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cytoplasms and positive segmented nuclei and ii) large
cells with large, positive nuclei. In the nasal mucosa
small positive cells predominated. They were located
subepithelially in the lamina propria (Figure 4). In the
mucosa of the pharyngeal tonsil, positive cells accumu-
lated around lymphatic follicules partially reaching the
mucosal surface. Single large positive cells as well as
small cells were found subepithelial in the tracheal mu-
cosa of healthy and diseased pigs. Within lymphnodes
PR-39-positve cells accumulated in the cortical and
medullar parenchyma, to a lesser extent in intermediary
and subcapsular sinuses, but not within the secondary
nodules. These regions are known to comprise lympho-
cytes, plasma cells, macrophages, and neutrophils.
According to their size and shape, PR-39 positive cells
resembled antigen-presenting cells with large bright nu-
clei (Figure 5). Unfortunately most antibodies for cell
markers in swine cannot be used for immunohisto-
chemistry in paraffin-embedded tissue. Using SWC3/
172a, as the first established porcine myelomonocytic
marker, a distinction between granulocytes, monocytes,
macrophages and plasmacytoic dendritic cells is not
possible [27]. In future studies staining protocols for
paraffin-embedded tissue have to be elaborated to test
available monoclonal antibodies against cell markers.Conclusion
The detection of PR-39 in cells of different shape, size,
and location indicates that this peptide is not restricted
to only one type of specific cell, but rather to various cell
types assigned to different functions within the network
of innate immune mechanisms. The morphology of cells
positive for PR-39 suggests PMNs. However, large im-
mune cells are also implied. A further characterisation
of the cells by double staining for PR-39 and swine mye-
lomonocytic differentiation antigens would be necessary
for a more precise identification of the positive cells.
The hypothesis that PR-39 is only detectable in dis-
eased pigs can be rejected. The presence of PR-39 intissue of the upper and lower respiratory tract of healthy
pigs shows that this antibacterial peptide might be im-
portant for maintaining health under the influence of
microorganisms and environmental factors.
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